Related Experiment Videos
Stroke patients' preferences and values about emergency research
1Department of Biostatistics and Epidemiology WB-4, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. blixenc@ccf.org
Journal of Medical Ethics
|October 4, 2005
Summary
Patients at risk for stroke support emergency research participation, even without explicit consent if a surrogate is unavailable. This highlights the need for clear communication regarding emergency research protocols.
Area of Science:
- Neurology
- Clinical Research Ethics
- Public Health
Background:
- The U.S. Food and Drug Administration (FDA) allows emergency research waivers of informed consent, contingent on community consultation.
- Defining the specific community or its representatives for consultation remains an unresolved challenge.
Purpose of the Study:
- To ascertain the preferences and values of individuals at risk for stroke concerning the FDA's waiver of informed consent for emergency research.
- To understand patient perspectives on participation in emergency stroke research.
Main Methods:
- Conducted face-to-face focused interviews with 12 patients hospitalized with a stroke diagnosis in the prior year.
- Utilized audiotaped interviews and transcript-based analysis to gather qualitative data.
Main Results:
- All participants emphasized the importance of developing new stroke treatments.
- Initially confused about "research for stroke" versus "emergency research for stroke," most (83%) agreed to participate in the latter after clarification.
- A significant majority (92%) preferred physicians to enroll them in trials if no surrogate was available during a stroke emergency.
Conclusions:
- This study provides initial insights into the values and concerns of stroke patients regarding emergency research.
- Further research, including validated questionnaires, is necessary to fully understand patient preferences in emergency stroke research.